LEGN
Legend Biotech Corporation
LEGN's outlook is improving, though it still trails on the overall score.
LLY
Eli Lilly and Company
LLY has the edge over LEGN overall, supported by lower modeled downside and stronger fundamentals.
LEGN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
LEGN's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LEGN PE Valuation
LEGN has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
LEGN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for LEGN, with profitability improving. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
LEGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.40 | +$0.82 |
| Q1 2026 | -$0.92 | +$0.06 |
| Q4 2025 | -$0.89 | -$0.02 |
| Q3 2025 | -$0.65 | +$1.09 |
| Q2 2025 | -$1.22 | +$0.18 |
| Q1 2025 | -$0.98 | +$1.46 |
| Q4 2024 | -$0.87 | +$2.09 |
| Q3 2024 | -$1.74 | +$1.27 |
LEGN is still losing money, but far less than before: $0.40 per share over the past year, against $3.32 at its worst in early 2023.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over LEGN on earnings quality, reporting a profit while its opponent remains loss making.
LEGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $387.5M | +52% |
| Q1 2026 | $305.1M | +56% |
| Q4 2025 | $306.4M | +64% |
| Q3 2025 | $272.3M | +70% |
| Q2 2025 | $255.1M | +37% |
| Q1 2025 | $195.1M | +108% |
| Q4 2024 | $186.5M | +135% |
| Q3 2024 | $160.2M | +67% |
LEGN has the edge over LLY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +64 points |
| Q1 2026 | -16% | +35 points |
| Q4 2025 | -6.7% | -28 points |
| Q3 2025 | -16% | +28 points |
| Q2 2025 | -49% | -26 points |
| Q1 2025 | -51% | +13 points |
| Q4 2024 | 22% | +173 points |
| Q3 2024 | -44% | +53 points |
LEGN's operating margin was 15% last quarter, up 64 points from the same quarter a year ago, near the top of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over LEGN on profitability, with a higher operating margin.
LEGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$41.5M | -$19.2M |
| Q1 2026 | -$111.3M | -$5.6M |
| Q4 2025 | -$126.6M | -$42.1M |
| Q3 2025 | $23.8M | +$101.7M |
| Q2 2025 | -$22.3M | -$17.2M |
| Q1 2025 | -$105.8M | -1240% |
| Q4 2024 | -$84.5M | +$18M |
| Q3 2024 | -$77.9M | -$11.6M |
LEGN has burned cash in almost every quarter: −$256M over the past year, against −$290M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over LEGN on cash generation, producing positive trailing cash flow while its opponent burns cash.
LEGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +9.1M shares |
| 1 year | -47% | -174M shares |
| 3 years | +11% | +18.5M shares |
| 5 years | +40% | +55.3M shares |
| Available history | +93% | +93.6M shares |
LEGN has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
LEGN Net Leverage
LEGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
LEGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 63.0 | Neutral |
LEGN's weekly RSI is 44 (neutral) and its Stochastic is 63 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
LEGN PE vs Healthcare Sector
LEGN has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
LEGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.7 | 5.9% below |
| 20 week MA | $20.9 | 11% below |
| 50 week MA | $22.1 | 16% below |
| 100 week MA | $28.2 | 34% below |
| 200 week MA | $42.3 | 56% below |
LEGN is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over LEGN on trend strength, trading above more of its moving averages.
LEGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.0 | $29.5 | -20% |
| 2021 | $29.5 | $48.7 | +65% |
| 2022 | $48.7 | $49.8 | +2.3% |
| 2023 | $49.8 | $60.2 | +21% |
| 2024 | $60.2 | $32.5 | -46% |
| 2025 | $32.5 | $22.5 | -31% |
| 2026 YTD | $22.5 | $18.5 | -18% |
LEGN has finished lower in three of the last six years. It's down 18% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over LEGN on returns for 2026, with the stronger performance.